文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

系统综述:健康与疾病状态下的胃部微生物群

Systematic review: gastric microbiota in health and disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-02-13

除幽门螺杆菌相关情况外,未能确定健康或疾病的总体胃部微生物群特征;胃癌发生过程伴随口腔和肠道菌群富集,质子泵抑制剂增加胃部微生物群丰富度,减重手术与粪便中潜在致病变形菌门增加相关。

要点

  • 幽门螺杆菌仍是胃部疾病最重要的单一风险因素,但其塑造整体胃部微生物群的能力尚待阐明。
  • 除幽门螺杆菌相关情况外,未能确定健康或疾病的总体胃部微生物群特征。
  • 质子泵抑制剂使用增加胃部微生物群丰富度,减重手术与粪便潜在致病变形菌门增加相关。

核心结论

  • 除幽门螺杆菌相关情况外,未能确定健康或疾病的总体胃部微生物群特征。
  • 幽门螺杆菌仍是胃部疾病最重要的单一风险因素,但其塑造集体胃部微生物群的能力尚未完全阐明。

研究设计与样本

  • 系统检索MEDLINE/EMBASE数据库1966年至2019年2月的文献,按照PRISMA指南筛选。
  • 纳入报告下一代测序衍生微生物群分析(胃抽吸物/组织或粪便样本)的随机对照试验、队列研究和观察性研究。

主要发现

  • 胃致癌过程诱导微生物群逐步改变,伴随口腔和肠道分类群富集以及宿主胃黏蛋白表达的显著变化。
  • 质子泵抑制剂使用增加胃部微生物群丰富度。
  • 减重手术与患者粪便样本中潜在致病变形菌门物种增加相关。

局限性

  • 除幽门螺杆菌诱导的情况外,无法确定健康或疾病的总体胃部微生物群特征。
  • 幽门螺杆菌塑造集体胃部微生物群的能力尚待完全阐明,需进一步研究宿主-微生物及微生物-微生物相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Helicobacter pylori is the most infamous constituent of the gastric microbiota and its presence is the strongest risk factor for gastric cancer and other gastroduodenal diseases. Although historically the healthy stomach was considered a sterile organ, we now know it is colonised with a complex microbiota. However, its role in health and disease is not well understood. AIM: To systematically explore the literature on the gastric microbiota in health and disease as well as the gut microbiota after bariatric surgery. METHODS: A systematic search of online bibliographic databases MEDLINE/EMBASE was performed between 1966 and February 2019 with screening in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Randomised controlled trials, cohort studies and observational studies were included if they reported next-generation sequencing derived microbiota analysis on gastric aspirate/tissue or stool samples (bariatric surgical outcomes). RESULTS: Sixty-five papers were eligible for inclusion. With the exception of H pylori-induced conditions, overarching gastric microbiota signatures of health or disease could not be determined. Gastric carcinogenesis induces a progressively altered microbiota with an enrichment of oral and intestinal taxa as well as significant changes in host gastric mucin expression. Proton pump inhibitors usage increases gastric microbiota richness. Bariatric surgery is associated with an increase in potentially pathogenic proteobacterial species in patient stool samples. CONCLUSION: While H pylori remains the single most important risk factor for gastric disease, its capacity to shape the collective gastric microbiota remains to be fully elucidated. Further studies are needed to explore the intricate host/microbial and microbial/microbial interplay.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Rajilic-Stojanovic M, Figueiredo C, Smet A, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020. PMID: 32056247. doi:10.1111/apt.15650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。